A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Head and neck cancer affects the Black community differently. These questions will help you make informed decisions about ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Patients who have completed colon cancer treatment could cut their risk of cancer-related death by 37% if they stick to a ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...

Multiple myeloma is considered incurable, but a third of patients in a clinical trial have lived without detectable cancer for years, after facing certain death ...

Investigators created a prognostic digital pathology-based AI score to identify a subset of patients with clinically high-risk prostate cancer more likely to benefit from the addition of abiraterone ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...